Cancer Archive — Page 35 of 69

March 12, 2020

Triple-negative breast cancer drug therapy shows promise

Researchers from Vanderbilt-Ingram Cancer Center (VICC) discovered a role for MYCN in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease, and identified a potential intervention for further clinical investigation.

March 9, 2020

Meat intake and colorectal polyps

Red and processed meat intakes are strongly associated with increased risk of sessile serrated polyps, which are not as well studied as conventional adenomas.

red and blue boxing gloves
March 5, 2020

One-two punch for cancer

A drug combination effectively killed aggressive blood cancers in cell and animal models; now it’s being tested in patients.

Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Maylee Wilshire served as Mayor of Smashville at the recent Nashville Predators Hockey Fights Cancer Night. Here, Wilshire drops the puck with Predators’ captain Roman Josi, left, and Columbus Blue Jackets’ captain Nick Foligno. Hockey Fights Cancer provides an opportunity to bring special guests from Children’s Hospital to Bridgestone Arena and to let the young hockey fans have a one-of-a-kind experience with the Nashville Predators. All money raised during the games benefits the 365 Pediatric Cancer Fund at Children’s Hospital to support childhood cancer initiatives.
March 5, 2020

Hockey Fights Cancer

Monroe Carell Jr. Children’s Hospital at Vanderbilt patient Maylee Wilshire served as Mayor of Smashville at the recent Nashville Predators Hockey Fights Cancer Night.

Dona Potter was treated with a new immunotherapy that entails re-engineering a patient’s T cells to target cancer.
February 27, 2020

Patient’s cancer treatment includes new immunotherapy

Dona Potter, 87, rode Harleys and drove 18-wheelers back when men dominated the open highways, and she is still defying expectations.

February 27, 2020

Breast cancer study may help predict treatment response

Researchers at VUMC are reporting another advance in the understanding and treatment of triple-negative breast cancer, which is particularly aggressive and difficult to treat.